Coeptis Therapeutics Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Coeptis Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2019 to Q3 2022.
  • Coeptis Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$80K, a 108% decline year-over-year.
  • Coeptis Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$3.36M, a 608% decline year-over-year.
  • Coeptis Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $784K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$3.36M -$80K -$1.08M -108% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$2.28M $10K +$99.2K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-02
Q1 2022 -$2.37M -$3.41M -$3.16M -1263% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $784K $121K +$123K Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 $661K $1M +$1.21M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$553K -$89.2K -$91.2K -4581% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$461K -$250K +$1.25M +83.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$1.71M -$1.87K -$1.87K Sep 1, 2020 Nov 30, 2020 10-Q 2021-01-11
Q3 2020 -$1.71M -$212K -$212K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.5M $1.99K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$1.5M Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-05-18
Q4 2019 $0 Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-11
Q3 2019 $0 Jun 1, 2019 Aug 31, 2019 10-Q/A 2020-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.